SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-24-097782
Filing Date
2024-09-06
Accepted
2024-09-06 17:01:49
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 tm2423330-1_424b5.htm 424B5 509789
2 GRAPHIC lg_gaintherapeutics-4c.jpg GRAPHIC 14481
3 GRAPHIC fc_pipeline-4clr.jpg GRAPHIC 60372
4 GRAPHIC fc_product-4clr.jpg GRAPHIC 59237
  Complete submission text file 0001104659-24-097782.txt   695621
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

IRS No.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-265061 | Film No.: 241285132
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)